$1.620
-0.039 (-2.41%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CRBU Prediction & Forecast by Similar Chart Analysis
Alphio's CRBU stock price prediction model matches the current Caribou Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.63 (+0.42%). The 1-week path is $1.64 (+1.21%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Caribou Biosciences Inc Stock?
Caribou Biosciences Inc is a good buy right now due to its recent FDA RMAT designation for its CAR-T therapy, which could accelerate market entry and enhance revenue potential. The stock has a gross margin of 100%, indicating strong profitability on sales, and analysts have set a price target of up to $13, suggesting a potential upside of over 800% from the current price. However, the company is currently facing a risk with a net income loss of $24.28 million in the most recent quarter, which investors should monitor closely.
CRBU stock price ended at $1.62 on Friday, after losing -2.41%
Caribou Biosciences Inc (CRBU) last closed at $1.62, losing -2.41%. These facts feed the 1-day and 1-week CRBU price prediction above.
Forecast Drivers
Caribou Biosciences Inc (CRBU) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CRBU, ranked by similarity.
Seasonality analysis for CRBU
Historically the probability of a positive August return for CRBU is 57.14%. August offers the highest probability of a positive month at 57.14%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CRBU
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.62 | $0.85 | $0.88 | -47.58% |
| Sep 2026 | $0.88 | $0.92 | $1.12 | -42.91% |
| Oct 2026 | $0.66 | $0.77 | $1.00 | -52.46% |
| Nov 2026 | $0.49 | $0.75 | $0.95 | -53.56% |
| Dec 2026 | $0.50 | $0.75 | $0.88 | -53.56% |
In 2026, Caribou Biosciences Inc (CRBU) is projected to range from $0.49 to $1.12.
Caribou Biosciences Inc 2026 monthly forecast
In Aug 2026, Caribou Biosciences Inc is projected to average $0.85, with a low of $0.62 and high of $0.88.
In Sep 2026, Caribou Biosciences Inc is projected to average $0.92, with a low of $0.88 and high of $1.12.
In Oct 2026, Caribou Biosciences Inc is projected to average $0.77, with a low of $0.66 and high of $1.00.
In Nov 2026, Caribou Biosciences Inc is projected to average $0.75, with a low of $0.49 and high of $0.95.
In Dec 2026, Caribou Biosciences Inc is projected to average $0.75, with a low of $0.50 and high of $0.88.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.